Herbal Product Use and Drug-Herbal Product Interactions in Patients with Chronic Diseases-A Cross-Sectional Study; [Kronik Hastalığı Olan Hastalarda Bitkisel Ürün Kullanımı ve İlaç-Bitkisel Ürün Etkileşimleri-Kesitsel Bir Anket Çalışması]

ArticleAçık Erişim

Özet

Herbal products are frequently used to prevent and treat diseases in the community. Although they are considered safe because they are natural, the simultaneous use of herbal products with drugs may cause drug-related problems and negatively affect therapeutic outcomes. Our study aimed to determine the herbal product use rates of patients with chronic diseases and the interactions of the herbal products used with drugs. This study is a cross-sectional survey conducted in a community pharmacy. The study included adult patients with chronic diseases who used regular drugs and had a history of using herbal products within the previous three months. The surveys included questions about patients’ demographics, diseases, drugs, and herbal products. Drug-herbal product interactions were examined through databases, monographs, and books. 93 of 148 patients were using herbal products. Most of the patients were diagnosed with hypertension and diabetes. The use of herbal products was found to be positively correlated with undergraduate educational status, asthma, COPD, diabetes, and anxiety (p<0.05). The herbal product that was most used and had the most drug interactions was garlic. The majority of drug-herbal product interactions were determined by the “drugs.com” interaction checking tool and the WHO monographs. Pharmacists should provide consultancy services to their patients on the use of herbal products. It is advisable for community pharmacists to keep their knowledge on drug-herbal product interactions updated. They can benefit from training programs on drug-herbal product interactions organized by clinical pharmacists. Thus, drug-herbal product interactions that may occur in patients can be reduced. © 2025 Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11360Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorPolat, Eyup Can
dc.contributor.authorGozcu, Sefa
dc.date.accessioned2026-10-18T20:26:25.460443452Z
dc.date.available2026-10-18T20:26:25.460443452Z
dc.date.issued2025
dc.description.abstractHerbal products are frequently used to prevent and treat diseases in the community. Although they are considered safe because they are natural, the simultaneous use of herbal products with drugs may cause drug-related problems and negatively affect therapeutic outcomes. Our study aimed to determine the herbal product use rates of patients with chronic diseases and the interactions of the herbal products used with drugs. This study is a cross-sectional survey conducted in a community pharmacy. The study included adult patients with chronic diseases who used regular drugs and had a history of using herbal products within the previous three months. The surveys included questions about patients’ demographics, diseases, drugs, and herbal products. Drug-herbal product interactions were examined through databases, monographs, and books. 93 of 148 patients were using herbal products. Most of the patients were diagnosed with hypertension and diabetes. The use of herbal products was found to be positively correlated with undergraduate educational status, asthma, COPD, diabetes, and anxiety (p<0.05). The herbal product that was most used and had the most drug interactions was garlic. The majority of drug-herbal product interactions were determined by the “drugs.com” interaction checking tool and the WHO monographs. Pharmacists should provide consultancy services to their patients on the use of herbal products. It is advisable for community pharmacists to keep their knowledge on drug-herbal product interactions updated. They can benefit from training programs on drug-herbal product interactions organized by clinical pharmacists. Thus, drug-herbal product interactions that may occur in patients can be reduced. © 2025 Society of Pharmaceutical Sciences of Ankara (FABAD). All rights reserved.
dc.identifier.doi10.55262/fabadeczacilik.1564728
dc.identifier.eissn2651-4648
dc.identifier.endpage156
dc.identifier.issn1300-4182
dc.identifier.issue1
dc.identifier.scopus2-s2.0-105001592936
dc.identifier.startpage145
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11360
dc.identifier.volume50
dc.language.isoen
dc.publisherSociety of Pharmaceutical Sciences of Ankara (FABAD)
dc.relation.ispartofFabad Journal of Pharmaceutical Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectchronic disease
dc.subjectclinical pharmacy
dc.subjectcommunity pharmacy
dc.subjectDrug-herbal product interactions
dc.subjectherbaceous agent
dc.subjectolanzapine
dc.subjectadult
dc.subjectanxiety
dc.subjectArticle
dc.subjectasthma
dc.subjectchronic obstructive lung disease
dc.subjectclinical pharmacist
dc.subjectcommunity pharmacist
dc.subjectcontrolled study
dc.subjectcross-sectional study
dc.subjectdiabetes mellitus
dc.subjecteducational status
dc.subjectfemale
dc.subjectgarlic
dc.subjectherb drug interaction
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectundergraduate student
dc.subjectWorld Health Organization
dc.titleHerbal Product Use and Drug-Herbal Product Interactions in Patients with Chronic Diseases-A Cross-Sectional Study; [Kronik Hastalığı Olan Hastalarda Bitkisel Ürün Kullanımı ve İlaç-Bitkisel Ürün Etkileşimleri-Kesitsel Bir Anket Çalışması]
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.trdizin0
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.oa.statusopen
rdl.source.indexSCOPUS
rdl.source.indexTRDIZIN